Publication:
Real-world experience of ocrelizumab in ms in the Turkish population: A single-center study

Simple item page
dc.contributor.authorCeylan, D.
dc.contributor.buuauthorSARIDAŞ, FURKAN
dc.contributor.buuauthorKoç, Erdem
dc.contributor.buuauthorTuran, Orhan
dc.contributor.buuauthorÖzkaya, Güven
dc.contributor.buuauthorÖZKAYA, GÜVEN
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentNefroloji Ana Bilim Dalı
dc.contributor.orcid0000-0003-4893-3988
dc.contributor.orcid0000-0001-5945-2317
dc.contributor.researcheridHSB-2700-2023
dc.date.accessioned2024-11-06T05:26:51Z
dc.date.available2024-11-06T05:26:51Z
dc.date.issued2022-07-01
dc.identifier.endpage792
dc.identifier.issn1351-5101
dc.identifier.issueSupplement1
dc.identifier.startpage792
dc.identifier.urihttps://hdl.handle.net/11452/47452
dc.identifier.volume29
dc.identifier.wos000815254003320
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherWiley
dc.relation.journalEuropean Journal Of Neurology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectClinical neurology
dc.subjectNeurosciences
dc.subjectNeurosciences & neurology
dc.titleReal-world experience of ocrelizumab in ms in the Turkish population: A single-center study
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Nefroloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Biyoistatistik Ana Bilim Dalı
relation.isAuthorOfPublication80b8fcdf-d916-4b3e-a7cb-00aebac954a7
relation.isAuthorOfPublication648e85b9-2f4f-4f92-a2d7-794286abd0fd
relation.isAuthorOfPublication.latestForDiscovery80b8fcdf-d916-4b3e-a7cb-00aebac954a7

Files

Collections

Yeni Yayınlar